We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · July 11, 2020

Next-Generation Sequencing Versus Cytogenetics in Patients With Suspected MDS

British Journal of Haematology

 

Additional Info

British Journal of Haematology
Clinical Value of Next-Generation Sequencing Compared to Cytogenetics in Patients With Suspected Myelodysplastic Syndrome
Br. J. Haematol 2020 Jun 25;[EPub Ahead of Print], E Kawata, A Lazo-Langner, A Xenocostas, CC Hsia, K Howson-Jan, U Deotare, L Saini, P Yang, R Broadbent, M Levy, C Howlett, A Stuart, J Kerkhof, S Santos, H Lin, B Sadikovic, I Chin-Yee

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading